Buy American Medical Supply Chain Act of 2020
Latest action · May 14, 2020 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 14, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Buy American Medical Supply Chain Act of 2020
This bill applies more stringent origination requirements (i.e., Buy American requirements) on commercially available off-the-shelf items procured for the Strategic National Stockpile. It also requires the Department of Health and Human Services to establish a program to support domestic production capacity for items in the stockpile.
Cosponsors 5
Members who signed on, in the order they did. Signatures ran from May 14, 2020 to Jul 13, 2020; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NJ | Jefferson Van Drew | Original | May 14, 2020 |
| D-DC | Eleanor Holmes Norton | May 15, 2020 | |
| D-CA | Gilbert Ray Cisneros, Jr. | May 15, 2020 | |
| D-CT | Jahana Hayes | May 15, 2020 | |
| D-PA | Matt Cartwright | Jul 13, 2020 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 14, 2020 |
| House | Oversight and Government Reform Committee | Referred May 14, 2020 |
Actions 2
Everything that happened, newest first.
- May 14, 2020Introduced in House
- May 14, 2020Referred to the Committee on Energy and Commerce, and in addition to the Committee on Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 91, May 14, 2020, page H2004.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46507 | FDA’s Role in the Medical Product Supply Chain and Considerations During COVID-19 Archived | Report | Sep 1, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To enhance American production of certain medical supplies, and for other purposes.
- Short Title(s) as Introduced
- Buy American Medical Supply Chain Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- May 14, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
